Details for Patent: 5,490,987

✉ Email this page to a colleague

Summary for Patent: 5,490,987

Patent landscape, scope, and claims:

Title:	Tableting of colestipol hydrochloride
Abstract:	The present invention provides a novel formulation of matter and a novel process for making it. In particular, the present invention provides unique and novel 1000 mg tablets of Colestipol hydrochloride having the advantageous properties of hardness and low friability and a novel process for making such tablets.
Inventor(s):	Shen; Robert W. (Kalamazoo, MI), Price; Jeffrey E. (Schoolcraft, MI)
Assignee:	The Upjohn Company (Kalamazoo, MI)
Application Number:	08/175,412
Patent Claim Types: see list of patent claims	Compound; Dosage form; Process;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 5,490,987

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,490,987

PCT Information
PCT Filed	June 23, 1992	PCT Application Number:	PCT/US92/05066
PCT Publication Date:	January 21, 1993	PCT Publication Number:	WO93/00915

International Family Members for US Patent 5,490,987

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	173931	⤷ Subscribe
Australia	2293392	⤷ Subscribe
Australia	669664	⤷ Subscribe
Canada	2110166	⤷ Subscribe
Czech Republic	286958	⤷ Subscribe
Czech Republic	9302826	⤷ Subscribe
Germany	69227773	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.